MAPK8 and breast carcinoma: Indeed, the data of this study showed that the phosphorylation levels of MAPK signaling (p-ERK and p-JNK, and p-p38 MAPK) were decreased by cantharidin treatment in MDA-MB-231 cells, confirming the hypothesis that cantharidin might regulate the MAPK signaling pathway in breast cancer.